Predicting response of molecular targeted therapies: a still possible challenge?

Ann Oncol. 2008 May;19(5):829-30. doi: 10.1093/annonc/mdn016. Epub 2008 Feb 21.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antibodies, Monoclonal / pharmacology
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Non-Small-Cell Lung / drug therapy
  • Cetuximab
  • Clinical Trials as Topic
  • Colorectal Neoplasms / drug therapy
  • Drug Delivery Systems*
  • ErbB Receptors / antagonists & inhibitors
  • Forecasting
  • Genes, erbB-1
  • Humans
  • Lung Neoplasms / drug therapy
  • Neoplasm Proteins / antagonists & inhibitors*
  • Patient Selection*
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Neoplasm Proteins
  • EGFR protein, human
  • ErbB Receptors
  • Cetuximab